NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathwayShuzhi Cui(Guangzhou Women and Children Medical Center), Yu Wei(Institut Pasteur)Research SquareApril 20, 202310.21203/rs.3.rs-2755109/v1Cited by 1SaveCiteExport RISWatch citationsRelated PapersNDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway|Nature Communications|2023|21CDC42 supports HBV entry by NTCP translocation to the plasma membrane and macropinocytosis|EMBO Reports|2025|2